KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- November 27, 2006 -- Sernova Corp. (“Sernova”) (TSX VENTURE: SVA) is pleased to announce the November issue of the medical journal, Diabetes, has published a breakthrough MRI method for monitoring the viability of transplanted pancreas islets. The technique was developed by the research group led by Dr. David White, Chair of Sernova’s Scientific Advisory Board, in collaboration with Dr. Paula Foster and the imaging group at the Robarts Research Institute in London, Ontario.
